Cargando…

Gene essentiality for tumour growth influences neoantigen‐directed immunoediting

Detalles Bibliográficos
Autores principales:	Bang, Hyoeun, Park, Jae Soon, Kim, Jeong Yeon, Sung, Changhwan, An, Jinhyeon, Cho, Dae‐Yeon, Lee, Se‐Hoon, Shim, Seok Bo, Choi, Jung Kyoon, Kim, Kwoneel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778643/ https://www.ncbi.nlm.nih.gov/pubmed/35060683 http://dx.doi.org/10.1002/ctm2.714

Ejemplares similares

DeepNeo: a webserver for predicting immunogenic neoantigens
por: Kim, Jeong Yeon, et al.
Publicado: (2023)

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
por: Łuksza, Marta, et al.
Publicado: (2022)

Genetic Architecture of Transcription and Chromatin Regulation
por: Kim, Kwoneel, et al.
Publicado: (2015)

Accelerated Evolution of the Regulatory Sequences of Brain Development in the Human Genome
por: Lee, Kang Seon, et al.
Publicado: (2020)

Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity
por: Kim, Kwoneel, et al.
Publicado: (2020)

Expression of tumour-specific antigens underlies cancer immunoediting
por: DuPage, Michel, et al.
Publicado: (2012)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Exosomes in cancer immunoediting and immunotherapy
por: Zhao, Yarong, et al.
Publicado: (2022)

Cancer Immunoediting and beyond in 2021
por: Borroni, Elena Monica, et al.
Publicado: (2021)

Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers
por: Su, Xiaofan, et al.
Publicado: (2022)

Global transcription network incorporating distal regulator binding reveals selective cooperation of cancer drivers and risk genes
por: Kim, Kwoneel, et al.
Publicado: (2015)

Lessons from Cancer Immunoediting in Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2012)

Cancer immunoediting: A game theoretical approach
por: Tavakoli, Fatemeh, et al.
Publicado: (2021)

Cancer stem cell immunoediting by IFNγ
por: Galassi, Claudia, et al.
Publicado: (2023)

Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories
por: Mizuno, Shinichi, et al.
Publicado: (2021)

Have Cells Harboring the HIV Reservoir Been Immunoedited?
por: Huang, Szu-Han, et al.
Publicado: (2019)

Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges
por: Kunimasa, Kei, et al.
Publicado: (2020)

Cancer immunoediting hypothesis: history, clinical implications and controversies
por: Lasek, Witold
Publicado: (2022)

Novel strategies for cancer immunotherapy: counter-immunoediting therapy
por: Liu, Shaochuan, et al.
Publicado: (2023)

Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance
por: Baird, Liam, et al.
Publicado: (2023)

Network perturbation by recurrent regulatory variants in cancer
por: Jang, Kiwon, et al.
Publicado: (2017)

Cancer immunoediting by the innate immune system in the absence of adaptive immunity
por: O’Sullivan, Timothy, et al.
Publicado: (2012)

A proposed role for neutrophil extracellular traps in cancer immunoediting
por: Berger-Achituv, Sivan, et al.
Publicado: (2013)

The Janus Face of Death Receptor Signaling during Tumor Immunoediting
por: O’ Reilly, Eimear, et al.
Publicado: (2016)

HTLV-1 as a Model for Virus and Host Coordinated Immunoediting
por: Mota, Talia M., et al.
Publicado: (2019)

Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics
por: Najaflou, Meysam, et al.
Publicado: (2022)

Tumour neoantigen mimicry by microbial species in cancer immunotherapy
por: Boesch, Maximilian, et al.
Publicado: (2021)

DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
por: Jung, Hyunchul, et al.
Publicado: (2019)

A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting
por: Pagura, Lucas, et al.
Publicado: (2014)

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
por: Efremova, Mirjana, et al.
Publicado: (2018)

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
por: Takeda, Kazuyoshi, et al.
Publicado: (2017)

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
por: Sonabend, Adam M., et al.
Publicado: (2021)

The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution
por: Nirmal, Ajit J., et al.
Publicado: (2022)

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2022)

Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
por: Houlahan, Kathleen E., et al.
Publicado: (2023)

Understanding Epistatic Interactions between Genes Targeted by Non-coding Regulatory Elements in Complex Diseases
por: Sung, Min Kyung, et al.
Publicado: (2014)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting
por: Matsushita, Hirokazu, et al.
Publicado: (2012)

Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth
por: Enderling, Heiko, et al.
Publicado: (2012)

Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma
por: Mazzocco, Marta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sft4i4rjp7bdtqjaofjckmim98